Misako Matsumoto Selected Research

Experimental Melanoma

4/2011	TLR2-dependent induction of IL-10 and Foxp3+ CD25+ CD4+ regulatory T cells prevents effective anti-tumor immunity induced by Pam2 lipopeptides in vivo.
10/2010	An embryo-specific expressing TGF-β family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Misako Matsumoto Research Topics

Disease

43	Neoplasms (Cancer) 01/2023 - 01/2002
35	Infections 01/2023 - 10/2002
18	Inflammation (Inflammations) 01/2023 - 03/2007
17	Virus Diseases (Viral Diseases) 02/2015 - 02/2002
10	Melanoma (Melanoma, Malignant) 01/2018 - 12/2006
6	Bites and Stings (Sting) 04/2018 - 01/2013
6	RNA Virus Infections 02/2014 - 10/2007
5	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020 - 04/2015
4	Hepatocellular Carcinoma (Hepatoma) 12/2007 - 01/2002
3	Human Influenza (Influenza) 12/2018 - 12/2017
3	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 01/2011
3	Necrosis 01/2013 - 05/2011
2	Communicable Diseases (Infectious Diseases) 01/2023 - 12/2022
2	Carcinogenesis 04/2013 - 10/2010
2	Experimental Melanoma 04/2011 - 10/2010
2	Vesicular Stomatitis 01/2009 - 12/2006
2	Bacterial Infections (Bacterial Infection) 03/2005 - 11/2004
1	Body Weight (Weight, Body) 01/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2022
1	Pruritus (Itching) 01/2020
1	Blister (Bulla) 01/2020
1	Pain (Aches) 01/2020
1	Erythema 01/2020
1	Lewis Lung Carcinoma 04/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018
1	Polyps 10/2017
1	Septic Shock (Toxic Shock Syndrome) 01/2017

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 12/2022 - 08/2002
19	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2004
18	Antiviral Agents (Antivirals)IBA 01/2023 - 02/2006
18	AntigensIBA 01/2023 - 11/2003
17	CytokinesIBA 01/2023 - 01/2004
15	LigandsIBA 01/2019 - 10/2007
15	Double-Stranded RNA (RNA, Double Stranded)IBA 04/2018 - 05/2002
14	Interferon Type IIBA 01/2018 - 12/2010
13	InterferonsIBA 04/2018 - 09/2011
12	Pattern Recognition ReceptorsIBA 01/2020 - 12/2006
12	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2018 - 11/2003
10	VaccinesIBA 01/2023 - 01/2011
10	Toll-Like Receptor 3IBA 12/2022 - 11/2003
10	Poly I-CIBA 04/2018 - 12/2006
7	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2014 - 12/2006
5	ChemokinesIBA 01/2023 - 08/2009
5	Nucleic AcidsIBA 01/2023 - 11/2014
5	Vaccine AdjuvantsIBA 12/2018 - 12/2015
5	DNA (Deoxyribonucleic Acid)IBA 04/2018 - 01/2013
5	Messenger RNA (mRNA)IBA 01/2018 - 03/2007
4	Neoplasm Antigens (Tumor Antigens)IBA 01/2019 - 01/2017
4	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2016 - 08/2002
3	Immunoglobulin A (IgA)IBA 12/2018 - 12/2017
3	OvalbuminIBA 07/2018 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2010
3	Transcription Factors (Transcription Factor)IBA 10/2017 - 12/2006
3	PAM2-CSK4IBA 01/2017 - 04/2011
3	CaspasesIBA 01/2017 - 08/2015
3	Interleukin-12 (IL 12)IBA 08/2016 - 12/2007
3	Viral RNAIBA 01/2013 - 09/2008
3	Complement System Proteins (Complement)IBA 12/2012 - 02/2002
3	Cell Wall SkeletonIBA 07/2010 - 05/2005
2	Cancer VaccinesIBA 01/2019 - 02/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2018 - 09/2012
2	Hemagglutinins (Hemagglutinin)IBA 12/2017 - 12/2007
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 08/2015
2	Toll-Like Receptor 2IBA 01/2017 - 12/2015
2	Viral DNAIBA 04/2015 - 01/2013
2	LipopeptidesIBA 02/2015 - 04/2011
2	Antigen-Antibody Complex (Immune Complex)IBA 08/2014 - 05/2011
2	Interferon-betaIBA 01/2012 - 01/2009
2	Monoclonal AntibodiesIBA 05/2011 - 04/2011
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2011 - 06/2008
2	Interleukin-23 (Interleukin 23)IBA 01/2011 - 06/2008
2	Protein Isoforms (Isoforms)IBA 03/2007 - 01/2002
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2005 - 11/2004
2	NF-kappa B (NF-kB)IBA 03/2005 - 11/2004
2	FlagellinIBA 03/2005 - 11/2004
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2023
1	aluminum sulfate (alum)IBA 01/2022
1	Bee Venoms (Bee Venom)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 12/2017
1	Immunoglobulins (Immunoglobulin)IBA 12/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2017
1	Interleukin-12 Subunit p40IBA 10/2017
1	Caspase 8 (Caspase-8)IBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	Toll-Like Receptor 4IBA 01/2017
1	Reactive Nitrogen SpeciesIBA 01/2017
1	Interleukin-33IBA 01/2016
1	AntibodiesIBA 01/2016
1	Interleukin-12 Subunit p35IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Genetic Markers (Genetic Marker)IBA 01/2016
1	nasIBA 11/2015

Therapy/Procedure

26	Immunotherapy 01/2020 - 11/2003
11	Therapeutics 01/2019 - 12/2007
1	Radiotherapy 04/2018
1	Intranasal Administration 01/2018
1	Subcutaneous Injections 08/2016